IPN60300: Clinical Trials

1 trial of IPN60300, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow IPN60300: new trials by email Literature Review of IPN60300 trials Research Report on IPN60300

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
IPN60300 - Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1 / Phase 2RecruitingIpsen1142025-12-052026-10-01

Conditions studied

Neoplasm Metastasis (1)

Sponsors

Ipsen (1)

Countries

France (1)  ·  Spain (1)  ·  United States (1)

NIH funding

2025 (1)